Really Good News

VERIFIED AGAINST INDEPENDENT SOURCES

Serious journalism about things going right.

We check every story against its sources before publishing — and we show the work. How we verify →

Health 1 SOURCE · UNCORROBORATED ≈US PATIENTS WITH SPINAL MUSCULAR ATROPHY ON EXISTING THERAPIES Sep 14, 2026

FDA approves Isembyld, first therapy for muscle loss in spinal muscular atrophy

The FDA approved Scholar Rock's drug Isembyld for US patients with spinal muscular atrophy aged 2 and older who are already on SMN2-targeting treatments. The drug is the first therapy to specifically target muscle loss in this condition. It is approved for use in combination with existing therapies, not as a standalone treatment, and its real-world effectiveness is not yet known.

Health 1 SOURCE · UNCORROBORATED ≈NATIONAL, RARE DISEASE POPULATION Reasonably substantiated Sep 12, 2026

FDA approves Isembyld to treat muscle loss in spinal muscular atrophy patients.

The FDA has approved Isembyld, a new drug to treat muscle loss in patients with spinal muscular atrophy (SMA). The drug is approved as an add-on to existing therapies for the national, rare disease population of people aged 2 and older. The approval was based on clinical trial improvements in motor skills, and long-term real-world outcomes are not yet known.

Health 1 SOURCE · UNCORROBORATED ≈21 U.S. STATES; THOUSANDS OF ILLNESSES Reasonably substantiated Sep 11, 2026

FDA declares end to largest cyclospora outbreak in U.S. history

Federal officials declared the end of what the FDA called the largest cyclospora food poisoning outbreak in U.S. history, which sickened thousands of people across 21 states. The exact case count was not provided.

Health 1 SOURCE · UNCORROBORATED ≈NATIONAL (US FDA AUTHORIZATION) Sep 11, 2026

FDA authorizes Queen of Hearts AI to triage harder-to-detect heart attacks.

The FDA has authorized an artificial intelligence algorithm called Queen of Hearts. The tool is designed to help clinicians identify harder-to-detect heart attacks from EKGs, a national authorization. The authorization was just issued, so the algorithm's impact in clinical practice is not yet proven.

Rights 1 SOURCE · UNCORROBORATED ≈CALIFORNIA STATEWIDE; PRIMARY DIRECT PROTECTIONS APPLY TO MINORS UNDER 16 WITHIN A STATE OF ROUGHLY 39 MILLION PEOPLE Sep 11, 2026

California bans addictive social media features for users under 16

California Governor Gavin Newsom signed 13 new laws that prohibit social media platforms from using addictive design features like infinite scrolling and algorithmic recommendations for users under 16. The laws apply statewide in California, a state of about 39 million people. The laws have been signed but their implementation and effects are not yet demonstrated, and legal challenges from technology companies are possible.

Health 1 SOURCE · UNCORROBORATED ≈ONE INDIVIDUAL Reasonably substantiated Sep 9, 2026

Girl with genetic deafness regains hearing after gene therapy in one ear

An 18-month-old girl born deaf due to an OTOF gene mutation can now hear sounds and has begun speaking. She received an experimental gene therapy infusion in her right ear at 11 months old as part of a Cambridge University trial. This is a single patient result from an early-stage trial, and the outcome has not yet been peer-reviewed, being based on clinician and family accounts. The long-term durability of the effect is not yet known.

Health 1 SOURCE · UNCORROBORATED ≈NATIONAL Sep 4, 2026

New Zealand approves pharmaceutical-grade MDMA for severe PTSD

New Zealand's national drug regulator, Medsafe, approved the prescription of pharmaceutical-grade MDMA for severe PTSD. The country is the second to approve such use after Australia. The approval is for prescriptions by two psychiatrists and does not yet confirm that the treatment has been delivered to patients.

Health 1 SOURCE · UNCORROBORATED ≈NATIONAL (U.S. APPROVAL) Sep 3, 2026

FDA approves first disease-modifying therapy for Alexander disease

The FDA approved Ionis Pharmaceuticals' drug Zanvastro as the first disease-modifying therapy for Alexander disease, a rare and deadly neurological disorder previously without approved treatment. The approval applies in the United States. Long-term real-world outcomes are not yet known.

Rights 1 SOURCE · UNCORROBORATED ≈NATIONAL Sep 3, 2026

Syria destroys 42 aerial bombs from former chemical weapons programme with OPCW verification

Syrian authorities destroyed 42 unfilled aerial bombs from the former Assad regime's chemical weapons programme. This is the first such destruction in Syria verified by the Organisation for the Prohibition of Chemical Weapons (OPCW) since 2014. The operation is national in scope, though it represents an initial step. More chemical materials, production facilities, and munitions remain to be destroyed, and future operations may be hampered by security conditions.

Climate 1 SOURCE · UNCORROBORATED ≈ONE SCHOOL Reasonably substantiated Sep 3, 2026

Community-based early warning system allowed evacuation of 900 students in Nepal before flood destroyed school

A community-based early warning system in Nepal facilitated the evacuation of 900 students minutes before a flood destroyed their school. This event involved one school. The account relies on a single source report by Mongabay, which substantiated the event through an interview with the head teacher.

Rights 1 SOURCE · UNCORROBORATED ≈NEIGHBORHOODS IN ONE CITY Reasonably substantiated Sep 1, 2026

Unarmed civilian safety practitioners reduced crime in three San Francisco neighborhoods

A study of San Francisco's Urban Alchemy program found that unarmed civilian practitioners reduced behavioral health-related and total crime in three neighborhoods. The analysis showed a modest reduction in drug crime and no change in property crime. This is a single study of neighborhoods in one city, so it is not clear if these results apply elsewhere.